Evidence Repository
The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • See Evidence submitted by expert panel for details.

Variant: NM_001042537.1(SLC9A6):c.25G>T (p.Ala9Ser)

CA295170

159933 (ClinVar)

Gene: SLC9A6
Condition: Christianson syndrome
Inheritance Mode: X-linked inheritance
Link to MONDO
UUID: b32cef3b-1a71-4c9f-9ec6-004e6cc38d60
Approved on: 2021-03-26
Published on: 2021-05-17

HGVS expressions

NM_001042537.1:c.25G>T
NM_001042537.1(SLC9A6):c.25G>T (p.Ala9Ser)
ENST00000370695.8:c.25G>T
ENST00000370701.6:c.-57+50G>T
ENST00000630721.3:c.-57+50G>T
ENST00000636092.1:c.-56-76G>T
ENST00000636347.1:c.-35-97G>T
ENST00000637195.1:c.-35-97G>T
ENST00000637234.1:c.-56-76G>T
ENST00000637581.1:c.-56-76G>T
ENST00000678163.1:c.25G>T
ENST00000370695.6:c.25G>T
ENST00000370698.7:c.25G>T
ENST00000370701.5:c.-57+50G>T
ENST00000627534.2:c.-57+55G>T
NM_001177651.1:c.-57+50G>T
NM_006359.2:c.25G>T
NM_001330652.1:c.-57+55G>T
NM_001177651.2:c.-57+50G>T
NM_001330652.2:c.-57+55G>T
NM_006359.3:c.25G>T
NM_001042537.2:c.25G>T
NM_001379110.1:c.-57+50G>T
NC_000023.11:g.135985527G>T
CM000685.2:g.135985527G>T
NC_000023.10:g.135067686G>T
CM000685.1:g.135067686G>T
NC_000023.9:g.134895352G>T
NG_017160.1:g.5101G>T
More

Benign

Met criteria codes 2
BP4 BA1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The allele frequency of the p.Ala9Ser variant in SLC9A6 is 0.307% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). Computational analysis prediction tools suggest that the p.Ala9Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own (BP4). In summary, the p.Ala9Ser variant in SLC9A6 is classified as benign based on the ACMG/AMP criteria (BA1, BP4).
Met criteria codes
BP4
Computational analysis prediction tools suggest that the p.Ala9Ser variant does not have a deleterious impact; however this information does not predict clinical significance on its own
BA1
The allele frequency of the p.Ala9Ser variant in SLC9A6 is 0.307% in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.